Type 2 Diabetes Mellitus and Invokana: An FDA Approved Drug

E-ISSN： 1875-6417|9|6|478-490

ISSN： 1573-3998

Source： Current Diabetes Reviews, Vol.9, Iss.6, 2013-11, pp. : 478-490

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Cardiovascular Effects of Metformin: Further Reasons to Consider An Old Drug as a Cornerstone in the Therapy of Type 2 Diabetes Mellitus

Current Vascular Pharmacology, Vol. 8, Iss. 3, 2010-05 ,pp. : 327-337

Bentham Science Publishers

Access to resources Recommend Favorite

Incretins, insulin secretion and Type 2 diabetes mellitus

By Vilsbøll T. Holst J.

Diabetologia, Vol. 47, Iss. 3, 2004-03 ,pp. : 357-366

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Science of Type 2 Diabetes Mellitus

By Salans L.B.

Trends in Endocrinology and Metabolism, Vol. 9, Iss. 1, 1998-01 ,pp. : 43-44

Elsevier

Access to resources Recommend Favorite

Type 2 Diabetes Mellitus and Cardiovascular Exercise Performance

By Regensteiner Judith G.

Reviews in Endocrine and Metabolic Disorders, Vol. 5, Iss. 3, 2004-08 ,pp. : 269-276

Springer Publishing Company

Access to resources Recommend Favorite

Antiosteoporotic Drugs and Incidence of Type 2 Diabetes Mellitus

By Kanazawa Ippei

Calcified Tissue International, Vol. 90, Iss. 2, 2012-02 ,pp. : 163-164

Springer Publishing Company

Access to resources Recommend Favorite